Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Renal Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07516366
What this trial is testing

Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

Who this might be right for
Clear Cell Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v8Stage III Renal Cell Cancer AJCC v8+1 more
National Cancer Institute (NCI) 16
Not applicableEnded earlyNCT05103722
What this trial is testing

Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma Metastatic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Large-scale testing (Phase 3)Active Not RecruitingNCT03937219
What this trial is testing

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Exelixis 855
Early research (Phase 1)Looking for participantsNCT06399419
What this trial is testing

CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell Carcinoma+5 more
Osel, Inc. 28
Not applicableWithdrawnNCT06554730
What this trial is testing

MSD Belzutifan PAS

Who this might be right for
Von Hippel Lindau Disease
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Looking for participantsNCT07167329
What this trial is testing

Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial

Who this might be right for
Von Hippel LindauVon Hippel Lindau DiseaseVon Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma+5 more
José Claudio Casali da Rocha 100
Testing effectiveness (Phase 2)Ended earlyNCT04267120
What this trial is testing

Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)

Who this might be right for
Renal Cell Carcinoma
Washington University School of Medicine 11
Early research (Phase 1)Ended earlyNCT04458259
What this trial is testing

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Who this might be right for
Neoplasm Metastasis
Pfizer 88
Testing effectiveness (Phase 2)Study completedNCT00003683
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
UNICANCER 40
Not applicableStudy completedNCT02156895
What this trial is testing

Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South Korea

Who this might be right for
Advanced Renal Cell Carcinoma
Pfizer 111
Testing effectiveness (Phase 2)WithdrawnNCT00311545
What this trial is testing

S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Study completedNCT00796757
What this trial is testing

Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC).

Who this might be right for
Renal Cell Cancer
Hoffmann-La Roche 146
Early research (Phase 1)Looking for participantsNCT07179770
What this trial is testing

Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC)

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
NYU Langone Health 12
Large-scale testing (Phase 3)Looking for participantsNCT03592472
What this trial is testing

Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

Who this might be right for
Renal Cell Carcinoma
Xynomic Pharmaceuticals, Inc. 413
Not applicableLooking for participantsNCT01109394
What this trial is testing

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

Who this might be right for
SarcomaEndocrine TumorsNeuroblastoma+2 more
National Cancer Institute (NCI) 6,035
Early research (Phase 1)UnknownNCT01381822
What this trial is testing

Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors

Who this might be right for
Advanced Renal Cell CarcinomaGastrointestinal Stromal TumorsPancreatic Neuroendocrine Tumors
Threshold Pharmaceuticals 58
Early research (Phase 1)Study completedNCT00944905
What this trial is testing

Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Who this might be right for
Renal Cell CarcinomaNon-hodgkin's Lymphoma
Bristol-Myers Squibb 46
Early research (Phase 1)Ended earlyNCT01144169
What this trial is testing

Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
University of Pittsburgh 7
Testing effectiveness (Phase 2)Looking for participantsNCT06794229
What this trial is testing

Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis

Who this might be right for
Locally Advanced Renal Cell Carcinoma
Qian Qin 69
Not applicableStudy completedNCT06656039
What this trial is testing

A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma, Clear Cell
RenJi Hospital 1,200
Next Page